Heaphy Lab

loading slideshow...

  • Breast TDLU

    Telomere and centromere-specific FISH with costaining for smooth muscle actin (magenta) and Ki67 (turquoise)

  • PanNET biomarkers

    Established tissue-based prognostic biomarkers for non-functional pancreatic neuroendocrine tumors.

  • Photoreceptors

    Telomere-specific FISH with colabeling for cone nuclei and processes (green) and rod nuclei (magenta)

  • Prostate Cancer TMA

    Telomere-specific FISH with costaining for a basal-specific cytokeratin (magenta) as well as NKX3.1 and FOXA1 (green)

  • Senescent fibroblasts

    Senescent fibroblasts can accumulate and produce senescence-associated secretory phenotype (SASP).

  • Lamin A/C in PrCa

    Costaining for a lamin A/C (green) and cytokeratin 8 in a prostate cancer

  • Ki67 in small intestine

    Ki67 (red) and lamin A/C (green) IF

  • ALT mechanism

    Break-induced replication mediates the extension of ALT telomeres

  • ALT+ PanNET

    Telomere-specific (red) and centromere-specific (green) FISH denotes the presence of ALT

  • Proposed PanNET model

    Multistep tumorigenesis of sporadic non-functional PanNETs

  • Telo-CISH

    Telo-CISH multiplex with basal-specific cytokeratin facilitates easy identification of short telomeres

HEAPHY LAB MISSION

We employ a multidisciplinary approach encompassing tissue-based, cell-based, and molecular methodologies to investigate the role of telomere alterations in the onset and progression of human diseases, with a particular focus on cancer (e.g., prostate cancer, pancreatic neuroendocrine tumors, breast cancer, sarcomas, and gliomas).

Our overarching goal is to advance the translation of molecular findings from tumors and the tumor microenvironment into clinical tools capable of accurately predicting cancer risk, prognosis, and responses to targeted therapies.

Central to our mission is cultivating a collaborative laboratory environment that supports professional growth and scientific exploration. We are dedicated to promoting diversity and inclusion within academia and medicine, and valuing the development of every member of our team, both personally and professionally.